GEM
NVO

Global Endowment Management’s Novo Nordisk NVO Stock Holding History

Global Endowment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-351,660
Closed -$9.44M – 233
2017
Q4 		$9.44M Hold
351,660
– – 1.38% 14
2017
Q3 		$8.47M Buy
351,660
+60,400
+21% +$1.36M 1.19% 12
2017
Q2 		$6.25M Buy
291,260
+61,260
+27% +$1.24M 0.85% 17
2017
Q1 		$3.94M Hold
230,000
– – 0.57% 18
2016
Q4 		$4.12M Hold
230,000
– – 0.64% 19
2016
Q3 		$4.78M Buy
+230,000
New +$5.7M 0.79% 22

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Global Endowment Management's NVO Position: Q1 2018 in Review

Global Endowment Management sold out of Novo Nordisk (NVO) in Q1 2018, closing a stake of 351,660 shares — an estimated $9.44M sold.

Global Endowment Management first reported a position in NVO in Q3 2016 and held it in 6 quarters. The position peaked at $9.44M in Q4 2017. 553 funds tracked by Wall St. Rank hold NVO as of Q1 2018.

  • Global Endowment Management reported no remaining Novo Nordisk position as of Q1 2018 after selling out during the quarter.
  • Global Endowment Management sold 351,660 Novo Nordisk shares in Q1 2018, an estimated $9.44M.
  • Global Endowment Management first reported a position in Novo Nordisk in Q3 2016 and held it in 6 quarters.
  • Global Endowment Management's Novo Nordisk position peaked at $9.44M in Q4 2017.
  • 553 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2018.

Based on Global Endowment Management's 13F filing for Q1 2018, filed 11 May 2018.